Alovudine F-18 Terminated Phase 1 Trials for Tumors of the Central Nervous System Diagnostic

IndicationsStatusPurposePhase
TerminatedDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT00633958A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors